{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:43:21Z","timestamp":1793371401865,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41401-020-00589-x","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T12:06:17Z","timestamp":1611576377000},"page":"1598-1609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction"],"prefix":"10.1038","volume":"42","author":[{"given":"Chak Kwong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Yun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Wai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Chi-shing","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Ching Wan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.","journal-title":"Nutr J"},{"key":"589_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12291-013-0373-5","volume":"29","author":"V Shenoy","year":"2014","unstructured":"Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P. Correlation of serum homocysteine levels with the severity of coronary artery disease. Indian J Clin Biochem. 2014;29:339\u201344.","journal-title":"Indian J Clin Biochem"},{"key":"589_CR3","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/01.CIR.101.13.1506","volume":"101","author":"EK Hoogeveen","year":"2000","unstructured":"Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes. Circulation. 2000;101:1506\u201311.","journal-title":"Circulation."},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/157340209788166940","volume":"5","author":"Z Cheng","year":"2009","unstructured":"Cheng Z, Yang X, Wang H. Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev. 2009;5:158\u201365.","journal-title":"Curr Hypertens Rev"},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.108.835223","volume":"120","author":"J Xu","year":"2009","unstructured":"Xu J, Zou MH. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation. 2009;120:1266\u201386.","journal-title":"Circulation."},{"key":"589_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/dmrr.660","volume":"23","author":"HC Looker","year":"2007","unstructured":"Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Sievers ML, Bennett PH, et al. Homocysteine and vitamin B12 concentrations and mortality rates in type 2 diabetes. Diabetes Metab Res Rev. 2007;23:193\u2013201.","journal-title":"Diabetes Metab Res Rev"},{"key":"589_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3923\/ijp.2014.200.212","volume":"10","author":"P Bhatia","year":"2014","unstructured":"Bhatia P, Gupta S, Sharma S. Homocysteine excess and vascular endothelium dysfunction: delineating the pathobiological mechanisms. Int J Pharmacol. 2014;10:200\u201312.","journal-title":"Int J Pharmacol."},{"key":"589_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/FJC.0000000000000176","volume":"65","author":"L Liu","year":"2015","unstructured":"Liu L, Liu J, Huang Y. Protective effects of glucagon-like peptide 1 on endothelial function in hypertension. J Cardiovasc Pharmacol. 2015;65:399\u2013405.","journal-title":"J Cardiovasc Pharmacol."},{"key":"589_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1152\/physrev.00003.2018","volume":"99","author":"H Jakubowski","year":"2019","unstructured":"Jakubowski H. Homocysteine modification in protein structure\/function and human disease. Physiol Rev. 2019;99:555\u2013604.","journal-title":"Physiol Rev"},{"key":"589_CR10","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3748\/wjg.v10.i12.1699","volume":"10","author":"C Ji","year":"2004","unstructured":"Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol. 2004;10:1699\u2013708.","journal-title":"World J Gastroenterol"},{"key":"589_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/iub.1292","volume":"66","author":"S Lenna","year":"2014","unstructured":"Lenna S, Han R, Trojanowska M. Endoplasmic reticulum stress and endothelial dysfunction. IUBMB Life. 2014;66:530\u20137.","journal-title":"IUBMB Life"},{"key":"589_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-12-800101-1.00002-8","volume":"121","author":"P Nadkarni","year":"2014","unstructured":"Nadkarni P, Chepurny OG, Holz GG. Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci. 2014;121:23\u201365.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"589_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.peptides.2011.05.003","volume":"32","author":"Y Li","year":"2011","unstructured":"Li Y, Li X, Zheng X, Tang L, Xu W, Gong M. Disulfide bond prolongs the half-life of therapeutic peptide-GLP-1. Peptides. 2011;32:1400\u20137.","journal-title":"Peptides."},{"key":"589_CR14","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.2337\/dc11-s231","volume":"34","author":"AJ Garber","year":"2011","unstructured":"Garber AJ. Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability. Diabetes Care. 2011;34:S279\u201384.","journal-title":"Diabetes Care"},{"key":"589_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","volume":"60","author":"L Liu","year":"2012","unstructured":"Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, et al. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon\u2013like peptide 1\u2013dependent mechanism. Hypertension. 2012;60:833\u201341.","journal-title":"Hypertension."},{"key":"589_CR16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/ATVBAHA.110.206425","volume":"30","author":"H Oeseburg","year":"2010","unstructured":"Oeseburg H, deBoer RA, Buikema H, van derHarst P, vanGilst WH, Sillje\u0301 HHW. Glucagon-like peptide 1 prevents reactive oxygen species\u2013induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol. 2010;30:1407\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"589_CR17","doi-asserted-by":"publisher","first-page":"e009379","DOI":"10.1161\/JAHA.118.009379","volume":"7","author":"R Bret\u00f3n\u2010Romero","year":"2018","unstructured":"Bret\u00f3n\u2010Romero R, Weisbrod RM, Feng B, Holbrook M, Ko D, Stathos MM, et al. Liraglutide treatment reduces endothelial endoplasmic reticulum stress and insulin resistance in patients with diabetes mellitus. J Am Heart Assoc. 2018;7:e009379.","journal-title":"J Am Heart Assoc"},{"key":"589_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/ATVBAHA.113.301938","volume":"34","author":"WS Cheang","year":"2014","unstructured":"Cheang WS, Tian XY, Wong WT, Lau CW, Lee SST, Chen ZY, et al. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5\u2032 adenosine monophosphate\u2013activated protein kinase\u2013peroxisome proliferator\u2013activated receptor \u03b4 pathway. Arterioscler Thromb Vasc Biol. 2014;34:830\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"589_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/db15-1657","volume":"66","author":"WS Cheang","year":"2017","unstructured":"Cheang WS, Wong WT, Zhao L, Xu J, Wang L, Lau CW, et al. PPAR\u03b4 is required for exercise to attenuate endoplasmic reticulum stress and endothelial dysfunction in diabetic mice. Diabetes. 2017;66:519\u201328.","journal-title":"Diabetes."},{"key":"589_CR20","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.2337\/db09-0685","volume":"58","author":"DA Cunha","year":"2009","unstructured":"Cunha DA, Ladri\u00e8re L, Ortis F, Igoillo-Esteve M, Gurzov EN, Lupi R, et al. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes. 2009;58:2851\u201362.","journal-title":"Diabetes."},{"key":"589_CR21","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, CuthillI C, Emerson M, Altman DG. NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol. 2010;160:1577\u20139.","journal-title":"Br J Pharmacol."},{"key":"589_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2011.05.009","volume":"14","author":"WT Wong","year":"2011","unstructured":"Wong WT, Tian XY, Xu A, Yu J, Lau CW, Hoo RLC, et al. Adiponectin is required for PPAR\u03b3-mediated improvement of endothelial function in diabetic mice. Cell Metab. 2011;14:104\u201315.","journal-title":"Cell Metab"},{"key":"589_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1161\/ATVBAHA.110.216044","volume":"31","author":"SL Wong","year":"2011","unstructured":"Wong SL, Lau CW, Wong WT, Xu A, Au CL, Ng CF, et al. Pivotal role of protein kinase C\u03b4 in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation. Arterioscler Thromb Vasc Biol. 2011;31:1169\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"589_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1089\/ars.2017.7005","volume":"28","author":"L Gou","year":"2018","unstructured":"Gou L, Zhao L, Song W, Wang L, Liu J, Zhang H, et al. Inhibition of miR-92a suppresses oxidative stress and improves endothelial function by upregulating heme oxygenase-1 in db\/db Mice. Antioxid Redox Signal. 2018;28:358\u201370.","journal-title":"Antioxid Redox Signal"},{"key":"589_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bcp.2017.04.007","volume":"136","author":"WC Ling","year":"2017","unstructured":"Ling WC, Liu J, Lau CW, Murugan DD, Mustafa MR, Huang Y. Treatment with salvianolic acid B restores endothelial function in angiotensin II-induced hypertensive mice. Biochem Pharmacol. 2017;136:76\u201385.","journal-title":"Biochem Pharmacol"},{"key":"589_CR26","doi-asserted-by":"publisher","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","volume":"289","author":"N Tyagi","year":"2005","unstructured":"Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Circ Physiol. 2005;289:H2649\u201356.","journal-title":"Am J Physiol Circ Physiol"},{"key":"589_CR27","first-page":"E947","volume":"310","author":"R Wei","year":"2016","unstructured":"Wei R, Ma S, Wang C, Ke J, Yang J, Li W, et al. Exenatide exerts direct protective effects on endothelial cells through the AMPK\/Akt\/eNOS pathway in a GLP-1 receptor-dependent manner. Am J Physiol Metab. 2016;310:E947\u201357.","journal-title":"Am J Physiol Metab"},{"key":"589_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10557-018-6820-z","volume":"32","author":"CK Cheng","year":"2018","unstructured":"Cheng CK, Bakar HA, Gollasch M, Huang Y. Perivascular adipose tissue: the sixth man of the cardiovascular system. Cardiovasc Drugs Ther. 2018;32:481\u2013502.","journal-title":"Cardiovasc Drugs Ther"},{"key":"589_CR29","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1089\/ars.2013.5519","volume":"21","author":"L Liu","year":"2014","unstructured":"Liu L, Liu J, Tian XY, Wong WT, Lau CW, Xu A, et al. Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress. Antioxid Redox Signal. 2014;21:1571\u201381.","journal-title":"Antioxid Redox Signal"},{"key":"589_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2015.01.011","volume":"83","author":"E Zito","year":"2015","unstructured":"Zito E. ERO1: a protein disulfide oxidase and H2O2 producer. Free Radic Biol Med. 2015;83:299\u2013304.","journal-title":"Free Radic Biol Med"},{"key":"589_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1158\/1541-7786.MCR-05-0221","volume":"3","author":"DE Feldman","year":"2005","unstructured":"Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res. 2005;3:597\u2013605.","journal-title":"Mol Cancer Res"},{"key":"589_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0968-0004(03)00057-4","volume":"28","author":"PJ Hogg","year":"2003","unstructured":"Hogg PJ. Disulfide bonds as switches for protein function. Trends Biochem Sci. 2003;28:210\u20134.","journal-title":"Trends Biochem Sci"},{"key":"589_CR33","doi-asserted-by":"publisher","first-page":"31010","DOI":"10.1074\/jbc.M113.510065","volume":"288","author":"J Wright","year":"2013","unstructured":"Wright J, Birk J, Haataja L, Liu M, Ramming T, Weiss MA, et al. Endoplasmic reticulum oxidoreductin-1\u03b1 improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress. J Biol Chem. 2013;288:31010\u20138.","journal-title":"J Biol Chem"},{"key":"589_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbrc.2018.02.095","volume":"497","author":"JQ Liu","year":"2018","unstructured":"Liu JQ, Zhang L, Yao J, Yao S, Yuan T. AMPK alleviates endoplasmic reticulum stress by inducing the ER-chaperone ORP150 via FOXO1 to protect human bronchial cells from apoptosis. Biochem Biophys Res Commun. 2018;497:564\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"589_CR35","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1074\/jbc.REV118.002804","volume":"294","author":"KFR Pobre","year":"2019","unstructured":"Pobre KFR, Poet GJ, Hendershot LM. The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: getting by with a little help from ERdj friends. J Biol Chem. 2019;294:2098\u2013108.","journal-title":"J Biol Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00589-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T11:40:52Z","timestamp":1634038852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00589-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00589-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}